April 4, 2025

Hysteroscopy Procedures Market Size to Cross USD 10.26 Billion by 2034

The global hysteroscopy procedures market size was valued at USD 4.84 billion in 2024 and is expected to cross around 10.26 billion by 2034, growing at a CAGR of 7.80% from 2025 to 2034.

Hysteroscopy Procedures Market Size 2025 to 2034

Get Sample Copy of Report@ https://www.precedenceresearch.com/sample/5731

Hysteroscopy Procedures Market Key Highlights

  • North America dominated the hysteroscopy procedures market with a 39% share in 2024, driven by advanced healthcare infrastructure.

  • Asia Pacific is set to witness a strong CAGR of 8.5%, supported by rising healthcare investments and medical advancements.

  • CPT code 58558 was the leading segment in 2024, holding 36% of the market share, reflecting its widespread usage.

  • The 58562 CPT code segment is anticipated to gain momentum in the coming years, driven by increasing procedural demand.

  • Hospitals retained the largest end-use market share of 53%, owing to the availability of specialized equipment and skilled professionals.

  • Ambulatory surgery centers are forecasted to see substantial growth, attributed to their cost-effective and efficient surgical procedures.

Hysteroscopy Procedures: An Overview

What is Hysteroscopy?
Hysteroscopy is a minimally invasive procedure used to examine and treat conditions inside the uterus. It involves the use of a hysteroscope, a thin, lighted tube inserted through the cervix to provide a clear view of the uterine cavity. This procedure is commonly performed for both diagnostic and operative purposes.

Types of Hysteroscopy

  1. Diagnostic Hysteroscopy

    • Used to diagnose uterine conditions such as abnormal bleeding, fibroids, polyps, and adhesions.

    • Often performed in an outpatient setting without anesthesia.

    • May be used in conjunction with other procedures like a biopsy or dilation and curettage (D&C).

  2. Operative Hysteroscopy

    • Used to treat uterine abnormalities, such as removing fibroids, polyps, and adhesions or correcting uterine septum.

    • Special surgical instruments are inserted through the hysteroscope for precise treatment.

    • Often performed under local, regional, or general anesthesia.

Common Applications of Hysteroscopy

  • Investigation of abnormal uterine bleeding.

  • Diagnosis and removal of uterine fibroids and polyps.

  • Treatment of uterine septum, adhesions (Asherman’s Syndrome), or endometrial abnormalities.

  • Removal of retained products of conception after miscarriage or abortion.

  • Fertility evaluations and assisted reproductive technology procedures.

Advantages of Hysteroscopy

  • Minimally invasive: No incisions are required, leading to a quicker recovery.

  • Shorter hospital stay: Many procedures can be done in outpatient settings.

  • Lower risk of complications: Compared to open or laparoscopic surgeries.

  • Faster recovery time: Patients can often return to normal activities within a few days.

Risks and Complications

Although hysteroscopy is generally safe, potential risks include:

  • Uterine perforation (rare but possible).

  • Infection or bleeding.

  • Fluid overload due to excessive absorption of distension media.

  • Cramping or mild pain post-procedure.

Market Insights for Hysteroscopy Procedures

  • Increasing demand: Growing prevalence of gynecological disorders and advancements in hysteroscopic techniques are driving market growth.

  • Technological advancements: The introduction of 3D hysteroscopic visualization and AI-assisted diagnostics is improving procedural efficiency.

  • Rising awareness: Increased awareness about minimally invasive procedures is boosting adoption rates globally.

  • Regional trends: North America and Europe dominate the market, while Asia Pacific is expected to witness rapid growth due to improved healthcare infrastructure.

Hysteroscopy Procedures Market Overview

The hysteroscopy procedures market is experiencing significant growth due to the rising prevalence of gynecological disorders such as abnormal uterine bleeding, fibroids, and polyps. The increasing adoption of minimally invasive procedures, along with advancements in hysteroscopic devices, is driving market expansion. Technological improvements, including AI-assisted diagnostics and robotic-assisted hysteroscopy, are enhancing procedure efficiency and accuracy. Growing awareness among women regarding reproductive health and the availability of better healthcare facilities are further contributing to the market’s positive trajectory.

Also Read: Automated Microbiology Market

Market Scope

Report Coverage Details
Market Size by 2034 USD 10.26 Billion
Market Size in 2025 USD 5.22 Billion
Market Size in 2024 USD 4.84 Billion
Market Growth Rate from 2025 to 2034 CAGR of 7.80%
Dominated Region North America
Fastest Growing Market Asia Pacific
Base Year 2024
Forecast Period 2025 to 2034
Segments Covered CPT Codes, End use, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Market Dynamics

Market Drivers

The key drivers of the hysteroscopy procedures market include the rising incidence of gynecological conditions, increasing demand for minimally invasive procedures, and technological advancements in hysteroscopic imaging and surgical tools. The growing geriatric female population and an increase in fertility-related treatments are also fueling market growth. Additionally, favorable reimbursement policies in developed regions and the growing preference for outpatient hysteroscopic procedures are boosting the market.

Market Opportunities

The market presents opportunities in the development of AI-integrated hysteroscopic systems that can enhance diagnostics and procedural accuracy. The rising demand for hysteroscopy in fertility treatments and reproductive health management is another key opportunity. Expansion into emerging markets, where healthcare infrastructure is improving, offers potential for market players. Furthermore, the growing focus on single-use hysteroscopes to prevent cross-contamination presents new growth avenues.

Market Challenges

Despite its growth, the market faces challenges such as high costs associated with advanced hysteroscopic procedures and limited access to specialized healthcare facilities in underdeveloped regions. The risk of complications such as infections and uterine perforation also poses a challenge to widespread adoption. Additionally, a lack of skilled professionals trained in advanced hysteroscopy techniques can limit market growth.

Regional Insights

North America dominates the hysteroscopy procedures market due to high healthcare spending, the presence of leading medical device manufacturers, and a strong focus on women’s health. Europe is also a key player, driven by favorable reimbursement policies and technological advancements. The Asia-Pacific region is expected to witness the fastest growth, fueled by increasing awareness of women’s health, rising disposable incomes, and improvements in healthcare infrastructure. Latin America and the Middle East & Africa are gradually adopting hysteroscopy procedures, with market expansion supported by government healthcare initiatives.

Hysteroscopy Procedures Market Companies

  • Medtronic
  • Stryker Corp.
  • Hologic, Inc.
  • KARL STORZ SE and Co. KG
  • Medical Devices Business Services, Inc. (Ethicon, Inc.)
  • Olympus Corp.
  • Delmont Imaging
  • B. Braun Melsungen AG
  • Richard Wolf GmbH
  • CooperCompanies
  • Maxer Endoscopy GmbH
  • Boston Scientific Corp.
  • MedGyn Products, Inc.
  • Lina Medical APS
  • Luminelle

Recent Developments

  • In April 2024, Nambour General Hospital unveiled its Outpatient Hysteroscopy Service, which provides hysteroscopies under local anesthetic in 1-2 hours duration, leading to reduced hospital stays from 6-14 hours previously and improved patient quality.
  • In July 2023, GenWorks presented its mechanical hysteroscopic tissue removal system. This system employs a simple mechanical technique to remove intrauterine tissues.
  • In May 2023, Olympus Corporation obtained FDA clearance for their EVIS X1 endoscopy system that they released with two matching gastrointestinal endoscopes as part of their innovative medical technology portfolio.

Segments Covered in the Report

By CPT Codes

  • 58555
  • 58558
  • 58562
  • 58340
  • 58563
  • 58565
  • 58353
  • 58561,74740
  • Others

By End Use 

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/